Showing 15 posts of 64 posts found.

India ‘likely’ to increase price caps

June 25, 2014
Manufacturing and Production, Sales and Marketing China, FDA, India, UK, pricing

India’s government is ‘likely’ to increase the number of drugs which are subject to price caps, according to a report …

LaMattina image

Drug prices defy gravity – until patent expiry

June 23, 2014
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina, LaMattina, Pfizer, drug, pharma, pricing, research

How drugs are priced is a hot topic these days, and a new Bloomberg article will cause it to heat-up …

Ireland agrees deal on medicines

June 28, 2012
Business Services, Sales and Marketing AstraZeneca, IPHA, Ireland, Lundbeck, Novartis, pricing

Ireland’s pharmaceutical industry has agreed a deal with the country’s government which breaks a deadlock over prices and access. The …

Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

Deepak Khanna

UK drug pricing: ABPI wants evolution, not revolution

June 14, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Deepak Khanna, MSD, PPRS, VBP, pricing

 As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

New drug discounts should be made transparent

February 8, 2012
Medical Communications, Sales and Marketing ABPI, NHS, NICE, access scheme, pricing

Patient access schemes agreed through NICE should be made more transparent.  This is according to Paul McManus, a pharmacist and …

Daiichi Sankyo: Europe poses huge challenge for pharma

June 9, 2011
Research and Development, Sales and Marketing Cancer, Daiichi Sankyo, pricing

Japanese pharma company Daiichi Sankyo is expanding its European operations, creating a new oncology business unit. But outlining its plans …

Price transparency and timing at risk, warns EFPIA

June 9, 2011
Sales and Marketing Drug pricing, EFPIA, medicines pricing, pricing

Europe’s pharmaceutical industry has warned that a review of EU law could undermine the pricing and reimbursement of medicines. The …

Andrew Lansley

Value-based pricing for UK pharma by 2014

July 13, 2010
Sales and Marketing government, pricing

The UK government plans to radically overhaul the way medicines are paid for, introducing a value-based pricing system within the …

Italy plans cancer drug price cut

July 7, 2010
Sales and Marketing Italy, economic climate, global pricing, price cuts, pricing

Italy will cut drug prices next year as it adopts a ‘pay for performance’ approach to drug pricing. This will …

Europe must move on from ‘simplistic’ pricing

June 22, 2010
Research and Development Europe, hta, pricing, pricing & Reimbursement

GSK chief executive Andrew Witty has called on European governments to scrap outdated pricing systems and embrace newer methods, in …

Andrew Witty

Let’s avoid further stand-offs, says Witty

June 22, 2010
Research and Development, Sales and Marketing EFPIA, Greece, industry, pricing

Pharma will need to find new ways of working with European governments in order to avoid further crises as witnessed …

Novo agrees price cut deal with Greece

June 16, 2010
Sales and Marketing Greece, Novo Nordisk, insulin, pricing

Novo Nordisk has agreed to resume supply of its insulins to the Greek market after pulling them last month as …

Implementing value-based pricing in the UK

June 14, 2010
Sales and Marketing hta, pricing, value

The UK has a strong history of innovation in medicines and it is vital to the economy that this continues …

Novo withdraws insulins in Greece price protest

May 31, 2010
Sales and Marketing Greece, pricing

Insulin manufacturer Novo Nordisk says it will withdraw its modern insulin products from Greece in protest at a 25% price …

Latest content